Goldman Sachs’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.6M | Buy |
+123,800
| New | +$36.8M | ﹤0.01% | 1837 |
|
|
2025
Q3 | – | Sell |
-8,000
| Closed | -$2.2M | – | 6372 |
|
|
2025
Q2 | $2.2M | Buy |
+8,000
| New | +$2.18M | ﹤0.01% | 4099 |
|
|
2023
Q1 | – | Sell |
-15,000
| Closed | -$2.52M | – | 5952 |
|
|
2022
Q4 | $2.52M | Sell |
15,000
-22,500
| -60% | -$3.91M | ﹤0.01% | 3752 |
|
|
2022
Q3 | $6.64M | Buy |
37,500
+5,500
| +17% | +$1.09M | ﹤0.01% | 2886 |
|
|
2022
Q2 | $6.55M | Buy |
32,000
+22,500
| +237% | +$4.77M | ﹤0.01% | 2888 |
|
|
2022
Q1 | $2.26M | Buy |
+9,500
| New | +$2.23M | ﹤0.01% | 4151 |
|
|
2021
Q4 | – | Sell |
-2,100
| Closed | -$406K | – | 6484 |
|
|
2021
Q3 | $406K | Sell |
2,100
-33,800
| -94% | -$6.85M | ﹤0.01% | 5320 |
|
|
2021
Q2 | $7.63M | Buy |
35,900
+6,300
| +21% | +$1.33M | ﹤0.01% | 2957 |
|
|
2021
Q1 | $6.04M | Buy |
+29,600
| New | +$5.83M | ﹤0.01% | 2965 |
|
|
2020
Q4 | – | Sell |
-1,200
| Closed | -$201K | – | 5505 |
|
|
2020
Q3 | $201K | Sell |
1,200
-3,000
| -71% | -$505K | ﹤0.01% | 4911 |
|
|
2020
Q2 | $683K | Sell |
4,200
-500
| -11% | -$89.6K | ﹤0.01% | 4205 |
|
|
2020
Q1 | $813K | Buy |
+4,700
| New | +$935K | ﹤0.01% | 3895 |
|
|
2018
Q3 | – | Sell |
-7,600
| Closed | -$1.25M | – | 5584 |
|
|
2018
Q2 | $1.25M | Sell |
7,600
-12,400
| -62% | -$2.03M | ﹤0.01% | 3935 |
|
|
2018
Q1 | $3.23M | Buy |
20,000
+19,600
| +4,900% | +$3.12M | ﹤0.01% | 3244 |
|
|
2017
Q4 | $58K | Sell |
400
-233,900
| -100% | -$33.3M | ﹤0.01% | 5907 |
|
|
2017
Q3 | $31.8M | Sell |
234,300
-97,600
| -29% | -$12.3M | 0.01% | 1622 |
|
|
2017
Q2 | $41.6M | Sell |
331,900
-398,100
| -55% | -$47.6M | 0.01% | 1362 |
|
|
2017
Q1 | $86.7M | Sell |
730,000
-34,000
| -4% | -$4.09M | 0.02% | 850 |
|
|
2016
Q4 | $88.1M | Buy |
764,000
+99,300
| +15% | +$11.1M | 0.02% | 863 |
|
|
2016
Q3 | $69.5M | Buy |
664,700
+544,000
| +451% | +$56.8M | 0.02% | 965 |
|
|
2016
Q2 | $11.8M | Buy |
120,700
+14,000
| +13% | +$1.32M | ﹤0.01% | 2188 |
|
|
2016
Q1 | $10.2M | Sell |
106,700
-20,500
| -16% | -$1.87M | ﹤0.01% | 2203 |
|
|
2015
Q4 | $11.5M | Buy |
127,200
+41,500
| +48% | +$3.91M | ﹤0.01% | 2146 |
|
|
2015
Q3 | $7.95M | Sell |
85,700
-12,900
| -13% | -$1.23M | ﹤0.01% | 2445 |
|
|
2015
Q2 | $9.18M | Sell |
98,600
-141,400
| -59% | -$13.2M | ﹤0.01% | 2406 |
|
|
2015
Q1 | $22.7M | Buy |
240,000
+153,100
| +176% | +$14.2M | 0.01% | 1662 |
|
|
2014
Q4 | $7.7M | Sell |
86,900
-114,200
| -57% | -$9.68M | ﹤0.01% | 2581 |
|
|
2014
Q3 | $16.1M | Buy |
201,100
+74,900
| +59% | +$5.64M | 0.01% | 1966 |
|
|
2014
Q2 | $8.95M | Sell |
126,200
-42,700
| -25% | -$3.01M | ﹤0.01% | 2464 |
|
|
2014
Q1 | $12.5M | Sell |
168,900
-130,200
| -44% | -$9.82M | ﹤0.01% | 2162 |
|
|
2013
Q4 | $23.5M | Sell |
299,100
-153,200
| -34% | -$12M | 0.01% | 1614 |
|
|
2013
Q3 | $33.4M | Sell |
452,300
-43,200
| -9% | -$3.18M | 0.01% | 1246 |
|
|
2013
Q2 | $37.6M | Buy |
+495,500
| New | +$32.5M | 0.01% | 1073 |
|
Other funds holding CME
VCM
VPM
Goldman Sachs's CME Position: Q1 2026 in Review
Goldman Sachs increased its CME Group (CME) stake by 11% in Q1 2026, buying an estimated $101M and bringing the position to 3,575,307 shares worth $1.06B. The position accounts for 0.12% of the portfolio, ranked #156.
Goldman Sachs first reported a position in CME in Q2 2013 and has held it in 52 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Goldman Sachs held 3,575,307 shares of CME Group worth $1.06B as of Q1 2026.
- Goldman Sachs bought 341,273 CME Group shares in Q1 2026, an estimated $101M.
- CME Group made up 0.12% of Goldman Sachs's portfolio in Q1 2026, its #156 holding.
- Goldman Sachs first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.